Catabasis Pharmaceuticals, Inc.
Records under this name other than patents Catabasis Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Catabasis Pharmaceuticals, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,708,245 | Fatty acid acylated salicylates and their uses Lapsed on the fee record Ended Jul 18, 2025 · From the USPTO record | Lapsed on the fee record | Ended Jul 18, 2025 | From the USPTO record |
| US RE45,275 | Fatty acid niacin conjugates and their uses Lapsed on the fee record Ended Nov 6, 2024 · From the USPTO record | Lapsed on the fee record | Ended Nov 6, 2024 | From the USPTO record |
| US 9,458,094 | Fatty acid acetylated salicylates and their uses Lapsed on the fee record Ended Oct 4, 2024 · From the USPTO record | Lapsed on the fee record | Ended Oct 4, 2024 | From the USPTO record |
| US 8,173,831 | Fatty acid acetylated salicylates and their uses Lapsed on the fee record Ended May 8, 2024 · From the USPTO record | Lapsed on the fee record | Ended May 8, 2024 | From the USPTO record |
| US 9,238,077 | Fatty acid niacin conjugates and their uses Lapsed on the fee record Ended Jan 19, 2024 · From the USPTO record | Lapsed on the fee record | Ended Jan 19, 2024 | From the USPTO record |
| US 9,139,516 | Fatty acid acetylated salicylates and their uses Lapsed on the fee record Ended Sep 22, 2023 · From the USPTO record | Lapsed on the fee record | Ended Sep 22, 2023 | From the USPTO record |
| US 9,085,527 | Fatty acid acylated salicylates and their uses Lapsed on the fee record Ended Jul 21, 2023 · From the USPTO record | Lapsed on the fee record | Ended Jul 21, 2023 | From the USPTO record |
| US 10,251,845 | Fatty acid cysteamine conjugates and their use as activators of autophagy Lapsed on the fee record Ended Apr 9, 2023 · From the USPTO record | Lapsed on the fee record | Ended Apr 9, 2023 | From the USPTO record |
| US RE46,605 | Fatty acid niacin conjugates and their uses Lapsed on the fee record Ended Jul 1, 2022 · From the USPTO record | Lapsed on the fee record | Ended Jul 1, 2022 | From the USPTO record |
| US RE46,608 | Fatty acid niacin conjugates and their uses Lapsed on the fee record Ended Jul 1, 2022 · From the USPTO record | Lapsed on the fee record | Ended Jul 1, 2022 | From the USPTO record |